Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment (ALTER)

This study has been completed.
The Government Pharmaceutical Organization
Chiang Mai University
Information provided by (Responsible Party):
Gonzague Jourdain, Institut de Recherche pour le Developpement Identifier:
First received: August 17, 2012
Last updated: May 28, 2015
Last verified: May 2015